Posard Matthew L.insider trades
In SEC Form 4 filings, Posard Matthew L. is listed as Director of Halozyme Therapeutics, Inc. (HALO). In the last 90 days, Posard Matthew L. sold $2.61M of Halozyme Therapeutics, Inc. (HALO) on the open market and bought none. All 8 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| HALOHalozyme Therapeutics, Inc. | Director | 8 | Oct 2 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| HALOHalozyme Therapeutics, Inc. | Oct 1 | Oct 2 | S | 730 | $107.17 | Sale −$78,233 | 58,109 | Yes | Form 4 |
| HALOHalozyme Therapeutics, Inc. | Oct 1 | Oct 2 | S | 3,300 | $108.45 | Sale −$357,898 | 54,809 | Yes | Form 4 |
| HALOHalozyme Therapeutics, Inc. | Oct 1 | Oct 2 | S | 1,100 | $109.57 | Sale −$120,526 | 53,709 | Yes | Form 4 |
| HALOHalozyme Therapeutics, Inc. | Oct 1 | Oct 2 | S | 100 | $110.04 | Sale −$11,004 | 53,609 | Yes | Form 4 |
| HALOHalozyme Therapeutics, Inc. | Sep 16 | Sep 17 | S | 3,100 | $106.13 | Sale −$329,009 | 74,735 | Yes | Form 4 |
| HALOHalozyme Therapeutics, Inc. | Sep 16 | Sep 17 | S | 3,000 | $106.83 | Sale −$320,484 | 71,735 | Yes | Form 4 |
| HALOHalozyme Therapeutics, Inc. | Sep 16 | Sep 17 | S | 8,896 | $108.04 | Sale −$961,124 | 62,839 | Yes | Form 4 |
| HALOHalozyme Therapeutics, Inc. | Sep 16 | Sep 17 | S | 4,000 | $108.99 | Sale −$435,964 | 58,839 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.